These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18574394)

  • 1. Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2.
    Sikuler E; Tur-Kaspa R; Shemer-Avni Y; Delgado J; Zilberman D; Fich A; Baruch Y; Hyam E
    J Clin Gastroenterol; 2008 Jul; 42(6):730-3. PubMed ID: 18574394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.
    Saito T; Ito T; Ishiko H; Yonaha M; Morikawa K; Miyokawa A; Mitamura K
    Am J Gastroenterol; 2003 Jun; 98(6):1377-83. PubMed ID: 12818284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.
    Huckans MS; Loftis JM; Blackwell AD; Linke A; Hauser P
    Subst Abuse Treat Prev Policy; 2007 Jan; 2():4. PubMed ID: 17222348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
    J Med Virol; 2009 Aug; 81(8):1354-62. PubMed ID: 19551828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome.
    de Almeida AJ; Campos-de-Magalhães M; Brandão-Mello CE; de Oliveira RV; do Espirito-Santo MP; Yoshida CF; Lampe E
    Hepatogastroenterology; 2009; 56(90):429-36. PubMed ID: 19579615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response.
    Donadel E; Pontisso P; Ruvoletto MG; Gerotto M; De Salvo G; Chemello L; Casarin C; Alberti A
    J Med Virol; 1998 Jan; 54(1):7-11. PubMed ID: 9443103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
    Oh HB; Kim SO; Cha CH; Hong SP; Folk WR; Kim KM; Suh DJ
    J Med Virol; 2008 Oct; 80(10):1712-9. PubMed ID: 18712825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
    Kinai E; Hanabusa H; Kato S
    J Med Virol; 2007 Aug; 79(8):1113-9. PubMed ID: 17596840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.
    Nattermann J; Vogel M; Nischalke HD; Danta M; Ahlenstiel G; Michalk M; Sauerbruch T; Rockstroh JK; Spengler U;
    AIDS; 2008 Jul; 22(11):1287-92. PubMed ID: 18580607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome.
    Silini E; Locasciulli A; Santoleri L; Gargantini L; Pinzello G; Montillo M; Foti L; Lisa A; Orfeo N; Magliano E; Nosari A; Morra E
    Haematologica; 2002 Nov; 87(11):1200-8. PubMed ID: 12414351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited success of HCV antiviral therapy in United States veterans.
    Cawthorne CH; Rudat KR; Burton MS; Brown KE; Luxon BA; Janney CG; Fimmel CJ
    Am J Gastroenterol; 2002 Jan; 97(1):149-55. PubMed ID: 11808940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do different hepatitis C virus genotypes behave differently?
    Amarapurkar DN; Patel ND; Rane P; Kamani P
    Trop Gastroenterol; 2007; 28(3):99-104. PubMed ID: 18383996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino acid sequence of the PKR-eIF2alpha phosphorylation homology domain of hepatitis C virus envelope 2 protein and response to interferon-alpha.
    Cochrane A; Orr A; Shaw ML; Mills PR; McCruden EA
    J Infect Dis; 2000 Nov; 182(5):1515-8. PubMed ID: 11023475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain.
    Martínez-Bauer E; Forns X; Armelles M; Planas R; Solà R; Vergara M; Fàbregas S; Vega R; Salmerón J; Diago M; Sánchez-Tapias JM; Bruguera M;
    J Hepatol; 2008 Jan; 48(1):20-7. PubMed ID: 17998149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function.
    Azevedo HA; Villela-Nogueira CA; Perez RM; Segadas-Soares JA; Takahashi C; Gaburo N; Pessoa I; Coelho HS
    J Nephrol; 2007; 20(5):609-16. PubMed ID: 17918148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C.
    Mailliard ME; Capadano ME; Hrnicek MJ; Gilroy RK; Gulizia JM
    Hepatology; 2009 Aug; 50(2):361-8. PubMed ID: 19585621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.